These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 16754884)
1. Inducing endogenous antimicrobial peptides to battle infections. Zasloff M Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8913-4. PubMed ID: 16754884 [No Abstract] [Full Text] [Related]
2. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Raqib R; Sarker P; Bergman P; Ara G; Lindh M; Sack DA; Nasirul Islam KM; Gudmundsson GH; Andersson J; Agerberth B Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9178-83. PubMed ID: 16740661 [TBL] [Abstract][Full Text] [Related]
3. Battle and balance at mucosal surfaces--the story of Shigella and antimicrobial peptides. Gudmundsson GH; Bergman P; Andersson J; Raqib R; Agerberth B Biochem Biophys Res Commun; 2010 May; 396(1):116-9. PubMed ID: 20494122 [TBL] [Abstract][Full Text] [Related]
4. Defending the epithelium. Zasloff M Nat Med; 2006 Jun; 12(6):607-8. PubMed ID: 16760999 [No Abstract] [Full Text] [Related]
5. Shigellae control the Gates of LL. Lehrer R Nat Med; 2001 Feb; 7(2):158-9. PubMed ID: 11175842 [No Abstract] [Full Text] [Related]
6. Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy. Sarker P; Ahmed S; Tiash S; Rekha RS; Stromberg R; Andersson J; Bergman P; Gudmundsson GH; Agerberth B; Raqib R PLoS One; 2011; 6(6):e20637. PubMed ID: 21673991 [TBL] [Abstract][Full Text] [Related]
7. Double-stranded RNA induces cathelicidin expression in the intestinal epithelial cells through phosphatidylinositol 3-kinase-protein kinase Cζ-Sp1 pathway and ameliorates shigellosis in mice. Ta A; Thakur BK; Dutta P; Sinha R; Koley H; Das S Cell Signal; 2017 Jul; 35():140-153. PubMed ID: 28343946 [TBL] [Abstract][Full Text] [Related]
8. Potent Inducers of Endogenous Antimicrobial Peptides for Host Directed Therapy of Infections. Ottosson H; Nylén F; Sarker P; Miraglia E; Bergman P; Gudmundsson GH; Raqib R; Agerberth B; Strömberg R Sci Rep; 2016 Nov; 6():36692. PubMed ID: 27827460 [TBL] [Abstract][Full Text] [Related]
9. Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014. Nüesch-Inderbinen M; Heini N; Zurfluh K; Althaus D; Hächler H; Stephan R Emerg Infect Dis; 2016 Jun; 22(6):1083-5. PubMed ID: 27191035 [TBL] [Abstract][Full Text] [Related]
10. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014. Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468 [TBL] [Abstract][Full Text] [Related]
11. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy. Cheasty T; Day M; Threlfall EJ Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014 [TBL] [Abstract][Full Text] [Related]
12. Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections. van der Does AM; Bergman P; Agerberth B; Lindbom L J Leukoc Biol; 2012 Oct; 92(4):735-42. PubMed ID: 22701042 [TBL] [Abstract][Full Text] [Related]
14. Defensins and cathelicidins in gastrointestinal infections. Wehkamp J; Schauber J; Stange EF Curr Opin Gastroenterol; 2007 Jan; 23(1):32-8. PubMed ID: 17133082 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility pattern, and associated factors of Salmonella and Shigella infections among under five children in Arba Minch, South Ethiopia. Ameya G; Tsalla T; Getu F; Getu E Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):1. PubMed ID: 29391040 [TBL] [Abstract][Full Text] [Related]